Mutations in the gene encoding the FMS-like tyrosine kinase 3 (FLT3) receptor tyrosine kinase occur in approximately 30% of acute myeloid leukemia (AML) cases, with internal tandem duplication (ITD) representing the most common type (25% of AML cases) [1]. The gene discussed is NTRK1; the disease is acute myeloid leukemia.